Skip to main content

Advertisement

SpringerLink
Log in

Glycolitic enzymes are targets of oxidation in aged human frontal cortex and oxidative damage of these proteins is increased in progressive supranuclear palsy

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary.

Progressive supranuclear palsy (PSP) is a neurodegenerative disorder pathologically characterized by neuronal loss and gliosis mainly in specific subcortical nuclei, but also in the cerebral cortex. In addition to neuron loss, hyperphosphorylated tau deposition is found in neurons, astrocytes and coiled bodies. Limited studies have shown that certain oxidative products are increased in the PSP brain. The present study examines oxidative damage in the frontal cortex in 7 PSP compared with 8 age-matched controls. Western blotting of the frontal cortex showed increased 4-hydroxy-2-nonenal (HNE)-immunoreactive bands between 40 and 50 kDa in PSP cases. Bi-dimensional gel electrophoresis and Western blotting, together with mass spectometry, were used to identify HNE-modified proteins. Oxidized phosphoglycerate kinase 1 (PGK-1) and fructose bisphosphate aldolase A (aldolase A) were identified in all cases and 4 of 7 PSP cases, respectively. In contrast, PGK-1 and aldolase A were oxidized in 3 of 8 controls. Immunohistochemistry revealed the localization of aldolase A in neurons and astrocytes, and PGK-1 mainly in astrocytes. These findings show that PGK-1 and aldolase A are targets of oxidation in the frontal cortex in the aged human cerebral cortex and that oxidative damage of these proteins is markedly increased in the frontal cortex in PSP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • DS Albers SJ Augood DM Martin DG Standaert JP Vonsattel MF Beal (1999) ArticleTitleEvidence for oxidative stress in the subthalamic nucleus in progressive supranuclear palsy J Neurochem 73 881–884 Occurrence Handle10428088 Occurrence Handle10.1046/j.1471-4159.1999.0730881.x Occurrence Handle1:CAS:528:DyaK1MXkslOqt74%3D

    Article  PubMed  CAS  Google Scholar 

  • DS Albers SJ Augood LC Park SE Browne DM Martin J Adamson M Hutton DG Standaert JP Vonsattel GE Gibson MF Beal (2000) ArticleTitleFrontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment J Neurochem 74 878–881 Occurrence Handle10646541 Occurrence Handle10.1046/j.1471-4159.2000.740878.x Occurrence Handle1:CAS:528:DC%2BD3cXntFyhtQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • ML Bigl J Apelt K Eschrich R Schliebs (2003) ArticleTitleCortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology J Neural Transm 110 77–94 Occurrence Handle12541014 Occurrence Handle1:CAS:528:DC%2BD3sXltlCisQ%3D%3D

    PubMed  CAS  Google Scholar 

  • D Boyd-Kimball R Sultana HF Poon BC Lynn F Casamenti G Pepeu JB Klein DA Butterfield (2005) ArticleTitleProteomic identification of proteins specifically oxidized by intracerebral injection of amyloid peptide (1–42) into rat brain: implications for Alzheimer’s disease Neuroscience 132 313–324 Occurrence Handle15802185 Occurrence Handle10.1016/j.neuroscience.2004.12.022 Occurrence Handle1:CAS:528:DC%2BD2MXivVyqu7g%3D

    Article  PubMed  CAS  Google Scholar 

  • L Buee T Bussiere V Buee-Scherrer A Delacourte PR Hof (2000) ArticleTitleTau protein isoforms, phosphorylation and role in neurodegenerative disorders Brain Res Rev 33 95–130 Occurrence Handle10967355 Occurrence Handle10.1016/S0165-0173(00)00019-9 Occurrence Handle1:CAS:528:DC%2BD3cXmtVCrtbY%3D

    Article  PubMed  CAS  Google Scholar 

  • I Cantuti-Castelvetri CE Keller-McGandy DS Albers MF Beal JP Vonsattel DG Standaert SJ Augood (2002) ArticleTitleExpression and activity of antioxidants in the brain in progressive supranuclear palsy Brain Res 930 170–181 Occurrence Handle11879807 Occurrence Handle10.1016/S0006-8993(02)02244-8 Occurrence Handle1:CAS:528:DC%2BD38XhslWis70%3D

    Article  PubMed  CAS  Google Scholar 

  • A Castegna M Aksenov V Thonboonkerd JB Klein WM Pierce R Booze W Markesbery DA Butterfield (2002) ArticleTitleProteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part II: Dihydropyrimidinase-related protein 2, α-enolase and heat shock cognate 71 J Neurochem 82 1524–1532 Occurrence Handle12354300 Occurrence Handle10.1046/j.1471-4159.2002.01103.x Occurrence Handle1:CAS:528:DC%2BD38XnsV2hsL4%3D

    Article  PubMed  CAS  Google Scholar 

  • A Delacourte L Buee (2000) ArticleTitleTau pathology: a marker of neurodegenerative disorders Curr Opin Neurol 13 371–376 Occurrence Handle10970052 Occurrence Handle10.1097/00019052-200008000-00002 Occurrence Handle1:STN:280:DC%2BD3M%2Fmt1KgtQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • DW Dickson (2001) Progressive supranuclear palsy and corticobasal degeneration PR Hof ChV Mobbs (Eds) Functional neurobiology of aging Academic Press San Diego 155–171

    Google Scholar 

  • JJ Hauw Y Agid (2003) Progressive supranuclear palsy (PSP) or Steele-Richardson-Olszewski disease D Dickson (Eds) Neurodegeneration: the molecular pathology of dementia and movement disorders ISN Neuropath Press Basel 103–114

    Google Scholar 

  • K Ikeda H Akiyama T Arai T Nishimura (1998) ArticleTitleGlial tau pathology in neurodegenerative diseases: their nature and comparison with neuronal tangles Neurobiol Aging 19 S85–S91 Occurrence Handle9562475 Occurrence Handle10.1016/S0197-4580(98)00034-7 Occurrence Handle1:STN:280:DyaK1c3itV2ltQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • H Karbe M Grond M Huber K Herholz J Kessler WD Heiss (1992) ArticleTitleSubcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography J Neurol 239 98–102 Occurrence Handle1552311 Occurrence Handle10.1007/BF00862982 Occurrence Handle1:STN:280:DyaK383gt12ltg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • T Komori (1999) ArticleTitleTau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick’s disease Brain Pathol 9 663–679 Occurrence Handle10517506 Occurrence Handle1:STN:280:DyaK1MvksFSqtg%3D%3D Occurrence Handle10.1111/j.1750-3639.1999.tb00549.x

    Article  PubMed  CAS  Google Scholar 

  • MA Korolainen G Goldsteins TA Nyman I Alafuzoff J Koistinaho T Pirttila (2006) ArticleTitleOxidative modification of proteins in the frontal cortex of Alzheimer’s disease brain Neurobiol Aging 27 42–53 Occurrence Handle16298240 Occurrence Handle10.1016/j.neurobiolaging.2004.11.010 Occurrence Handle1:CAS:528:DC%2BD2MXht1egsr3L

    Article  PubMed  CAS  Google Scholar 

  • WM Lee M Goedert JQ Trojanowski (2001) ArticleTitleNeurodegenerative tauopathies Annu Rev Neurosci 24 1121–1159 Occurrence Handle11520930 Occurrence Handle10.1146/annurev.neuro.24.1.1121 Occurrence Handle1:CAS:528:DC%2BD3MXls1Shsbo%3D

    Article  PubMed  CAS  Google Scholar 

  • I Litvan (2004) ArticleTitleUpdate on progressive supranuclear palsy Curr Neurol Neurosci Rep 4 296–302 Occurrence Handle15217544 Occurrence Handle10.1007/s11910-004-0055-z

    Article  PubMed  Google Scholar 

  • I Litvan JJ Hauw JJ Bartko PL Lantos SE Daniel DS Horoupian A McKee D Dickson C Bancher M Tabaton K Jellinger DW Anderson (1996) ArticleTitleValidity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders J Neuropathol Exp Neurol 55 97–105 Occurrence Handle8558176 Occurrence Handle1:STN:280:DyaK287js1Wlsw%3D%3D Occurrence Handle10.1097/00005072-199601000-00010

    Article  PubMed  CAS  Google Scholar 

  • HR Morris G Gibb R Katzenschlager NW Wood DP Hanger C Strand T Lashley SE Daniel AJ Lees BH Anderton T Revesz (2002) ArticleTitlePathological, clinical and genetic heterogeneity in progressive supranuclear palsy Brain 125 969–975 Occurrence Handle11960887 Occurrence Handle10.1093/brain/awf109 Occurrence Handle1:STN:280:DC%2BD383pslCqsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • P Odetti S Garibaldi R Norese G Angelini L Marinelli S Valentini S Menini N Traverso D Zaccheo S Siedlak G Perry MA Smith M Tabaton (2000) ArticleTitleLipoperoxidation is selectively involved in progressive supranuclear palsy J Neuropathol Exp Neurol 59 393–397 Occurrence Handle10888369 Occurrence Handle1:CAS:528:DC%2BD3cXjsFGjsbw%3D

    PubMed  CAS  Google Scholar 

  • B Puig MJ Rey I Ferrer (2005) ArticleTitleIndividual and regional variations of phospho-tau species in progressive supranuclear palsy Acta Neuropathol 110 261–268 Occurrence Handle15973541 Occurrence Handle10.1007/s00401-005-1046-0 Occurrence Handle1:CAS:528:DC%2BD2MXhtVektrvP

    Article  PubMed  CAS  Google Scholar 

  • l Rampello V Buttà R Raffaele I Vecchio G Battaglia G Cormaci A Alvano (2005) ArticleTitleProgressive supranuclear palsy: a systematic review Neurobiol Dis 20 179–186 Occurrence Handle16242626 Occurrence Handle10.1016/j.nbd.2005.03.013 Occurrence Handle1:STN:280:DC%2BD2Mrms1Ohsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • T Scaravilli E Tolosa I Ferrer (2005) ArticleTitleProgressive supranuclear palsy and corticobasal degeneration: lumping versus splitting Mov Disord 20 IssueIDSuppl 12 S21–S28 Occurrence Handle16092076 Occurrence Handle10.1002/mds.20536

    Article  PubMed  Google Scholar 

  • MG Spillantini M Goedert (1998) ArticleTitleTau protein pathology in neurodegenerative diseases Trends Neurosci 21 428–433 Occurrence Handle9786340 Occurrence Handle10.1016/S0166-2236(98)01337-X Occurrence Handle1:CAS:528:DyaK1cXmsVartr0%3D

    Article  PubMed  CAS  Google Scholar 

  • R Sultana SF Newman HM Abdul J Cai WM Pierce JB Klein M Merchant DA Butterfield (2006) ArticleTitleProtective effect of D609 against amyloid-beta1–42-induced oxidative modifications on neuronal proteins: redox proteomics studies J Neurosci Res 84 409–417 Occurrence Handle16634065 Occurrence Handle10.1002/jnr.20876 Occurrence Handle1:CAS:528:DC%2BD28XnvFaiu7c%3D

    Article  PubMed  CAS  Google Scholar 

  • K Tawana DB Ramsden (2001) ArticleTitleProgressive supranuclear palsy Mol Pathol 54 427–434 Occurrence Handle11724919 Occurrence Handle1:CAS:528:DC%2BD38XnvFSjsbY%3D

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut de Neuropatologia, Servei Anatomia Patològica, IDIBELL-Hospital Universitari de Bellvitge, Universitat de Barcelona, Hospitalet de Llobregat, Barcelona, Spain

    A. Martínez, E. Dalfó, G. Muntané & I. Ferrer

Authors
  1. A. Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Dalfó
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Muntané
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Ferrer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. Ferrer.

Additional information

Correspondence: Isidre Ferrer, Institut de Neuropatologia, Servei Anatomia Patològica, IDIBELL-Hospital Universitari de Bellvitge, carrer Feixa Llarga sn, Hospitalet de Llobregat, 08907 Barcelona, Spain

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martínez, A., Dalfó, E., Muntané, G. et al. Glycolitic enzymes are targets of oxidation in aged human frontal cortex and oxidative damage of these proteins is increased in progressive supranuclear palsy. J Neural Transm 115, 59–66 (2008). https://doi.org/10.1007/s00702-007-0800-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-007-0800-y

Search

Navigation